Engineered anti-prostate stem cell antigen (psca) antibodies...

C - Chemistry – Metallurgy – 12 – P

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12P 21/08 (2006.01) A61K 39/395 (2006.01) C07K 16/00 (2006.01) C12P 21/04 (2006.01) G01N 33/574 (2006.01) C07H 21/04 (2006.01)

Patent

CA 2646329

The invention provides novel humanized antibody fragments that specifically bind prostate cell-surface antigen (PSCA), a protein which is overexpressed in variety of cancers, including prostate, bladder, and pancreatic cancer. Methods are provided for the use of the compositions of the invention for the treatment of cancer, diagnosis of cancer, to provide a prognosis of cancer progression, and for cancer imaging.

La présente invention concerne de nouveaux fragments d'anticorps humanisés qui se lient spécifiquement à l'antigène de surface de cellules prostatiques (PSCA), une protéine qui est surexprimée dans une multitude de cancers, y compris les cancer de la prostate, de la vessie et du pancréas. Cette invention concerne des méthodes d'utilisation des compositions de cette invention pour le traitement, le diagnostic et le pronostic de l'évolution du cancer, ainsi que pour l'imagerie du cancer.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Engineered anti-prostate stem cell antigen (psca) antibodies... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Engineered anti-prostate stem cell antigen (psca) antibodies..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Engineered anti-prostate stem cell antigen (psca) antibodies... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1807784

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.